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Summary
Triggering of lymphocyte antigen receptors is the crit-
ical first step in the adaptive immune response against
pathogens. T cell receptor (TCR) ligation assembles
a large membrane signalosome, culminating in NF-
kB activation [1, 2]. Recently, caspase-8 was found to
play a surprisingly prominent role in lymphocyte acti-
vation in addition to its well-known role in apoptosis
[3]. Caspase-8 is activated after TCR stimulation
and nucleates a complex with B cell lymphoma 10
(BCL10), paracaspase MALT1, and the inhibitors of
kB kinase (IKK) complex [4]. We now report that the
ubiquitin ligase TRAF6 binds to active caspase-8
upon TCR stimulation and facilitates its movement
into lipid rafts. We identified in silico two putative
TRAF6 binding motifs in the caspase-8 sequence [5]
and found that mutation of critical residues within
these sites abolished TRAF6 binding and diminished
TCR-induced NF-kB activation. Moreover, RNAi-medi-
ated silencing of TRAF6 abrogated caspase-8 recruit-
ment to the lipid rafts. Protein kinase Cq (PKCq),
CARMA1, and BCL10 are also required for TCR-in-
duced caspase-8 relocation, but only PKCq and
BCL10 control caspase-8 activation. Our results sug-
gest that PKCq independently controls CARMA1 phos-
phorylation and BCL10-dependent caspase-8 activa-
tion and unveil an essential role for TRAF6 as
a critical adaptor linking these two convergent signal-
ing events.
Results and Discussion
To study caspase-8 and TRAF6 during TCR stimulation,
we employed an assay for the in situ trapping of active
caspase-8 [4, 6]. Jurkat cells were pretreated with an ir-
reversible covalent inhibitor of active caspases (biotin-
conjugated valine-alanine-aspartate-fluoromethylke-
tone, b-VAD), and active caspase-8 was isolated before
and after TCR stimulation. In this approach, caspases
are blocked by the inhibitor as soon as they become ac-
tivated and can be precipitated and quantified [6]. b-
VAD was also added to lysates 10 min after stimulation
for comparison. b-VAD efficiently bound to active un-
processed caspase-8 after TCR ligation in both condi-
tions, but more precipitation was observed in
*Correspondence: lenardo@nih.govposttreated samples, suggesting that an amplification
loop of caspase-8 activation may occur during TCR
stimulation (Figure 1A). We also found that TRAF6 co-
precipitated with the active fraction of caspase-8 follow-
ing TCR stimulation (Figure 1A).
Immunoprecipitation of TRAF6 revealed that it inter-
acts with BCL10, caspase-8, and IKKb in a stimulus-de-
pendent manner. By contrast, deficiency in caspase-8
(I9.2 Jurkat cells) dramatically reduced TRAF6, BCL10,
and IKKb association (Figure 1B). We inferred that active
caspase-8 and TRAF6 form a complex following TCR
stimulation. Moreover, caspase-8 appears to be a cen-
tral nexus in this so-called activation receptor-induced
signalosome (ARIS) [7], because no association of these
molecules occurs in cells lacking caspase-8 (I9.2). Using
glutathione S-transferase (GST) pull-down experiments,
we found that in vitro-translated TRAF6 binds to GST-
caspase-8 (Figure 1C), suggesting that these two mole-
cules directly interact without additional cofactors. Cas-
pase-8 is part of a DED-containing gene cluster located
on chromosome 2q33-34, together with caspase-10 and
the apoptosis inhibitor cFLIPL. Because these three
molecules are structurally related, they may have arisen
from duplication of a common ancestral gene [8]. We
therefore tested whether caspase-10 and cFLIPL could
also interact with TRAF6 when overexpressed in
HEK293T. Figure 1D shows that TRAF6 efficiently pre-
cipitated caspase-8, but not caspase-10. As previously
documented, we failed to detect any interaction be-
tween TRAF6 and cFLIPL (Figure 1E) [9]. Hence, TRAF6
binding seems to be a specific function of caspase-8.
Examination of the caspase-8 sequence revealed two
putative TRAF6 binding sites, PDEADF (residues 395–
400) and PAEGTW (residues 416–420), located in the
NH2-terminal portion of the small subunit (Figure 2A)
[5]. Interestingly, neither TRAF6 binding motif was pres-
ent in the cFLIP sequence, while only the first motif oc-
curred in caspase-10 (see Figure S1 in the Supplemental
Data available with this article online), suggesting that
both sites in caspase 8 may be involved in TRAF6 dock-
ing. A single substitution of the glutamic acid to an ala-
nine residue in this consensus motif strongly diminishes
TRAF6 binding capacity [5]. To test the importance of
these sites for TRAF6 binding to caspase 8, we mutated
both E396 and E417 into alanine residues (reported as
2EA-Casp8). Although 2EA-Casp8 and wild-type cas-
pase-8 (wt-Casp8) were expressed at similar levels
and induced comparable cell death in HeLa and Jurkat
cells (Figures S2, S3, and S5), 2EA-Casp8 association
with FLAG-TRAF6 was barely detectable when expres-
sion constructs were cotransfected in HEK293T cells
(Figures 2B and 2C). Mutation in each individual motif
only partially reduced TRAF6 binding (data not shown).
We next investigated whether this mutant could func-
tionally interfere with the ability of caspase-8 to induce
NF-kB. Overexpression of 2EA-Casp8 only marginally
promoted NF-kB transcriptional activity compared to
wt-Casp8 (Figure 2D). Moreover, 2EA-Casp8 markedly
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1667Figure 1. Caspase-8 Interaction with TRAF6 Following T Cell Receptor Stimulation
(A) Jurkat cells (53 107) preloaded with 20 mM biotinylated-VAD (b-VAD) for 30 min at 37C (‘‘pre’’) were stimulated with 2 mg/ml anti-CD3 and anti-
CD28 for 10 min. Another part of the cells was stimulated, and lysates were incubated with 5 mM b-VAD (‘‘post’’). Lysates were then incubated
with streptavidin-coated beads, and precipitates were analyzed by immunoblotting for the presence of caspase-8 and TRAF6. Endogenously
biotinylated acetyl-CoA carboxylase serves as a loading control for the pretreated samples.
(B) TRAF6 coimmunoprecipitation with caspase-8, IKKb, and BCL10 in wild-type (A3) and caspase-8-deficient (I9.2) Jurkat cells stimulated with
anti-CD3/CD28 for the indicated time.
(C) In vitro-translated full-length TRAF6 and a mock control vector were incubated with GST-caspase-8 or GST alone, and GST pull-down was
performed to assess the binding between TRAF6 and caspase-8.
(D and E) Expression vectors encoding FLAG-TRAF6, HA/GFP-caspase-8, HA/GFP-caspase-10, and cFLIPL were transfected into HEK293T
cells. Lysates were immunoprecipitated with an anti-FLAG antibody and then analyzed by immunoblotting with antibodies to caspase-8,
caspase-10, cFLIP, and FLAG. Endo-Casp8, endogenous caspase-8; ns, nonspecific band.reduced TRAF6-induced NF-kB activity (Figure 2E). Fi-
nally, ectopic expression of 2EA- but not wt-Casp8
strongly reduced TCR-induced NF-kB activation in Ju-
rkat cells (Figure 2F and Figure S6). These results sug-
gest that the specific interaction between TRAF6 and
caspase-8 is required to convey the NF-kB signal during
TCR stimulation. Also, our results indicate that 2EA-
Casp8 acts as a dominant negative, probably by binding
to endogenous wild-type caspase-8.
Enrichment of critical molecules in lipid raft microdo-
mains has been recognized as an essential step for
TCR signal transduction [10]. Indeed, 3-phosphoinosi-
tide-dependent-kinase 1 (PDK1) controls the accumula-
tion of the PKCq and the membrane-associated
CARMA1 protein in lipid rafts following TCR engage-
ment [11]. There, PKCq phosphorylates CARMA1 on
specific serine residues in its linker region [12, 13].
This allows the subsequent recruitment of a fraction of
the cytosolic BCL10, MALT1, and IKK proteins required
to transmit the NF-kB activating signal [11, 14–16]. Be-
cause caspase-8 was shown to interact with BCL10and IKK (Figure 1) [4], we investigated whether a fraction
of caspase-8 was also recruited to the lipid rafts during
TCR stimulation. Isolation of detergent-insoluble lipid
raft fractions showed a significant enrichment in cas-
pase-8 along with BCL10, TRAF6, and IKKb, after TCR
stimulation (Figure 3A). Of note, the raft fraction of
BCL10 exhibited a slightly higher molecular mass, de-
tected as a doublet. This is consistent with a posttrans-
lational phosphorylation of BCL10 once recruited to the
plasma membrane [17]. Raft association of these mole-
cules was transient and peaked at 15–30 min following
TCR stimulation in both Jurkat and primary T lympho-
cytes (Figures 3B and 3C). Cells deficient in caspase-8
exhibited reduced recruitment of IKKb and BCL10, but
not TRAF6, in the lipid raft fractions (Figure 3D and
Figure S7).
CARMA1 is tethered by a lipid moiety to the mem-
brane and is crucial for NF-kB induction [2]. To deter-
mine whether CARMA1 reorganization in lipid rafts
was affected in the absence of caspase-8, I9.2 and A3
cells were treated with fluorescent cholera toxin (CTX),
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(A) Caspase-8 harbors two potential TRAF6 binding motifs PXEXXAc/Ar, located in the NH2-terminal portion of the small subunit.
(B and C) IP/WB analysis of TRAF6 interactions with wild-type caspase-8 (wt-Casp8) and E396A/E417A double mutant (2EA-casp8) in HEK293T
cells expressing the indicated constructs. Input fractions (25 mg) are also shown (input) for each sample. Data represent one out of three
experiments.
(D) GFP, wt-Casp8, or the TRAF6-interaction mutant (2EA-Casp8) constructs were transfected into HEK293T cells together with an NF-kB-
dependent luciferase reporter gene to assess their ability to activate NF-kB. The results shown were from triplicate experiments and normalized
for transfection efficiency (RLU, relative light units).
(E) HEK293T cells were transfected and analyzed as in (C) with FLAG-TRAF6 in combination with wild-type or 2EA-Casp8 expression constructs.
(F) TCR-induced NF-kB activation is decreased by a 2EA-Casp8 in Jurkat cells. Cells were transfected with 20 mg empty vector or 2EA-Casp8 for
24 hr and then stimulated for 6 hr with the indicated amounts of CD3 and CD28 antibodies. Fold increase in NF-kB luciferase activity from
triplicate experiments is shown.which binds to the GM1 ganglioside within the rafts.
Crosslinking of CD3 triggered similar aggregation of
CD3 and CARMA1 with CTX in both A3 and I9.2, sug-
gesting that caspase-8 acts downstream or in parallel
to CARMA1 (Figure 3E and Figure S8). We next investi-
gated whether knockdown of TRAF6 interfered with cas-
pase-8 redistribution to the lipid rafts. In addition, we
also treated the cells with specific siRNA to PKCq and
BCL10. As reported previously [18–21], knockdown of
each of these molecules drastically reduced TCR-in-
duced NF-kB activity (Figure 3F). The recruitment of cas-
pase-8 to lipid rafts was significantly reduced in the ab-
sence of TRAF6, BCL10, or PKCq upon TCR stimulation
(Figures 3G and 3H). Finally, we tested a CARMA1-defi-
cient Jurkat cell line (JPM50.6) [22]. We only detected
PKCq accumulation in lipid rafts after TCR stimulation,
while caspase-8, BCL10, TRAF6, and IKK remained in
the cytosol (Figure 3I). In conclusion, PKCq, CARMA1,BCL10, and TRAF6 all regulate caspase-8 recruitment
into lipid rafts upon TCR stimulation.
To further characterize the function of TRAF6 and
BCL10 in caspase-8 oligomerization/activation, we uti-
lized b-VAD precipitation assays to assess TCR-in-
duced caspase-8 activation status in cells transfected
with different siRNA. Interestingly, in cells depleted of
TRAF6, caspase-8 was normally activated and still asso-
ciated with BCL10 upon TCR ligation. In contrast, there
was an almost complete abrogation of TCR-induced
caspase-8 activation in cells transfected with BCL10
siRNA (Figure 4A). Similarly, knockdown of PKCq with
two independent siRNA sequences also prevented cas-
pase-8 activation (Figure 4B). Hence, PKCq and BCL10,
but not TRAF6, are required for caspase-8 activation
during TCR stimulation. Interestingly, RNAi-mediated si-
lencing of these molecules had no impact on caspase-8-
dependent apoptosis induced by Fas crosslinking
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1669Figure 3. Regulation of Caspase-8 Recruitment to the Lipid Rafts by PKCq, BCL10, TRAF6, and CARMA1
(A) Immunoblotting (IB) for IKKb, caspase-8, BCL10, TRAF6, and the constitutively raft-associated protein Lck in the insoluble (raft) and soluble
(cytosol) fractions isolated from A3 Jurkat cells (53 107) stimulated 15 min with or without crosslinked anti-CD3 and anti-CD28. Equal volumes of
representative fractions was collected.
(B and C) IB with anti-caspase-8, BCL10, TRAF6, IKKb, and Lck in the pooled lipid raft and detergent-soluble fractions of Jurkat (B), and primary
lymphocytes (C) that were stimulated for the indicated time.
(D) IB on raft recruitment of IKKb, BCL10, TRAF6, and Lck in the caspase-8-deficient (I9.2) Jurkat cells treated as in (A).
(E) Quantitation of the fraction of cells showing CARMA1 aggregation following TCR stimulation in the wild-type (A3) and caspase-8-deficient
(I9.2) Jurkat cells, as evaluated by fluorescence microscopy.
(F) NF-kB luciferase assay of A3 Jurkat cells that were transfected with siRNA specific for PKCq, BCL10, MALT1, or TRAF6, or scrambled siRNA
(NS) for 4 days. The efficiency of the siRNA was assessed by IB with the indicated antibodies (left panel). Two days following siRNA transfection,
cells were transfected again with the same siRNA plus an NF-kB-dependent luciferase reporter gene, then stimulated with anti-CD3 and anti-
CD28 for 6 hr on day 4. Data shown are from triplicate experiments and normalized by transfection efficiency.
(G and H) IB of indicated proteins in the raft and cytosolic fractions of A3 cells (53 107) transfected for 4 days with the indicated siRNA and stim-
ulated as in (A).
(I) IB of PKCq, caspase-8, BCL10, TRAF6, IKKg, and Lck in the raft and cytosolic fractions of CARMA1-deficient Jurkat cells (JPM50.6) that were
stimulated as in (A).(Figure S9). Thus, these two caspase-8-activating plat-
forms function independently in causing NF-kB activa-
tion or cell death. Finally, caspase-8 activation was not
affected in the CARMA1-deficient JPM50.6 cell line
(Figure 4C). In keeping with the data from Figure 3, this
suggests that caspase-8 is first activated in the cytosol
by forming a complex with BCL10 in a PKCq-dependent
manner, and then is shuttled to the lipid rafts through
TRAF6 and CARMA1 (Figure 4D).
Taken together, these results show that caspase-8 as-
sociation with TRAF6 is critical for the active protease to
move into lipid rafts and propagate NF-kB signaling.
Why transient enzymatic activity of caspase-8 is re-
quired for TCR-induced NF-kB is still a conundrum,with at least two possibilities [23]. It is conceivable that
caspase-8 cleaves an unknown substrate, promoting
NF-kB activation. In this scenario, one appealing candi-
date is the caspase-8 regulator cFLIP [8]. Indeed, T cells
from cFLIPL-transgenic mice exhibit an enhanced prolif-
eration when exposed to suboptimal TCR stimulation
[24], and activation triggers greater caspase-8 and NF-
kB activities [25]. Moreover, it was recently shown that
cFLIP can be cleaved by active, full-length caspase-8
into an NH2-terminal p22 fragment, which strongly trig-
gers NF-kB activity [26]. However, cFLIP involvement
in TCR-induced NF-kB signaling is still controversial,
as no obvious defects in TCR-induced NF-kB or ERK ac-
tivation were reported in thymocytes from mice with
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1670Figure 4. PKCq and BCL10, but Not CARMA1 and TRAF6, Regulate Caspase-8 Activation during TCR Stimulation
(A) Jurkat cells were transfected with siRNA specific for BCL10 or TRAF6 or a nonspecific sequence (NS) for 4 days. Cells were then preincubated
with 20 mM b-VAD, then stimulated with 2 mg/ml anti-CD3 and anti-CD28 for 10 min. Lysates were then precipitated with streptavidin-coated
beads, and the presence of active caspase-8 was detected by IB. Acetyl-CoA carboxylase served as a control for precipitation and loading.
The extent of BCL10 and TRAF6 knockdown was assessed in extracts of total cell lysate (input).
(B) Analysis of caspase-8 activation in cells transfected with two different siRNA targeting PKCq, as determined in (A). Efficient knockdown is
confirmed by IB of total cell extracts collected prior to b-VAD precipitation.
(C) Caspase-8 activation in wild-type (A3), CARMA1-deficient (JPM50.6), and caspase-8-deficient (I9.2) Jurkat cells preincubated with 20 mM b-
VAD and stimulated for 5 and 10 min with anti-CD3 and anti-CD28. Lysates were precipitated with streptavidin and further immunoblotted
against caspase-8 and acetyl-CoA carboxylase.
(D) ‘‘Signal bifurcation’’ model for TCR-induced NF-kB activation: TCR stimulation leads to the activation of PKCq, which both phosphorylates
CARMA1 and independently promotes the formation of a complex containing caspase-8, BCL10, and MALT1. TRAF6 is recruited into this com-
plex and promotes its movement to the lipid rafts. This triggers IKK complex recruitment and activation and subsequent NF-kB activation.a conditional cFLIP deletion in the T cell compartment
[27, 28]. None of the known components of the signaling
complex appear to be cleaved by active caspase-8 (N.B.
and M.J.L., unpublished data). Alternatively, caspase-8
may assume a different conformation in its active state
that enhances the binding and/or ubiquitin ligase activ-
ity of TRAF6, without cleavage of a specific substrate.
Indeed, our data suggest that caspase-8 stimulation
triggers an autoamplification loop, resulting in more ac-
tive caspase-8 and better TRAF6 recruitment. Recently,
Sun et al. identified MALT1 as a binding partner for
TRAF6. Moreover, high molecular weight oligomers of
BCL10 and MALT1 recruit and enhance TRAF6 ubiquitin
ligase activity, culminating with NEMO ubiquitination
[20]. Thus, active multimerized caspase-8 may partici-
pate with MALT1 in increasing local concentrations of
TRAF6 necessary to catalyze IKK activation after TCR
stimulation. Indeed, our preliminary data suggest that
caspase-8 alone can also affect TRAF6-mediated
NEMO ubiquitination (A.L.S., N.B., and M.J.L., unpub-
lished data).
How external signals like TCR ligation trigger the re-
cruitment of the cytosolic components of the ARIS tothe immunological synapse remains unknown. PKCq
phosphorylates CARMA1 in its linker region [12, 13],
switching CARMA1 from an inactive, closed conforma-
tion to an open conformer capable of accepting cyto-
solic cargo into the immunological synapse. [29]. How-
ever, these events occur at the plasma membrane and
fail to explain how other cytosolic partners are recruited
there. Our present results suggest that, in addition to
phosphorylating CARMA1, PKCq is essential for the for-
mation of a cytosolic complex comprising at least cas-
pase-8, BCL10, and MALT1 through a distinct yet unde-
termined signal transduction event. As the proposed
model illustrates (Figure 4D), TRAF6 might function as
a critical linker between this caspase-8-containing com-
plex and phosphorylated-CARMA1 following the bifur-
cation of signals emanating from activated PKCq. In
the future, it will be interesting to define the protein(s)
linking PKCq to the nucleation of cytosolic proteins
around active caspase-8. Since caspase-8 deficiency
causes severe immunodeficiency in humans and exper-
imental animals, it is clear that this mechanism plays a
vital role in protective immunity [3, 4, 10]. Hence, a
better understanding of the precise molecular pathway
TRAF6 and Caspase-8 Interaction Signals NF-kB
1671promises to shed light on various unexplained immuno-
deficiency disorders as well as on normal immune
function.
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